OTC - ACTIVE INGREDIENT SECTION
Active ingredient
Benzoyl Peroxide 2.5%
Active ingredient
Benzoyl Peroxide 2.5%
Purpose- Acne Treatment
Uses. For the treatment of acne
Warning : For external use only
Avoid unnecessary sun exposure and use sunscreen.
Avoid contact with eye, If product gets into eyes, rinse thoroughly with water.
If excessive irritation occurs reduce application to once a day. Using other topical acne medication at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, consult a doctor.
Keep out of reach of children.
Direction:
After cleansing and toning apply lotion over the entire face. Use daily. If going outside use a sunscreen
Allow Clearogen to dry then follow directions in the sunscreen labeling. If irritation or sensitivity develops, discontinue use of all products, and consult a doctor.
Not applicable
Inactive Ingredient:
Aqua (Water), Linolenic Acid (Alpha & Gamma), Linoleic Acid,Glycerin, Glycine Soja (Soyabean) Sterols, Dodecyl Gallate, Octyl Ethylhexyl Gallate, Serenoa Serrulata Fruit Extract, Caprylic/Capric Triglyceride, Cetearyl Alcohol & Dicetyl Phosphate & Ceteth-10 Phosphate, Dimethicone, Aloe Barbadensis Leaf Extract, Glyceryl Stearate & PEG-100 Stearate, Sodium Hyaluronate, Cetyl Alcohol, Caprylyl Glycol, Phenoxyethanol,Extract of Malva Sylvestris (Mallow), Mentha Piperita (Peppermint) Leaf Extract, Primula Veris Extract, Alchemilla Vulgaris Extract, Veronica Officinalis Extract, Melissa Officinalis Leaf Extract, Achillea Millefolium Extract, Imperata Cylindrica Root Extract, Stearic Acid, Symphytum Officinale Extract, Camellia Oleifera(Green Tea)Leaf Exact, Tocopherol, Plantago Ovata Seed Extract, Hydrolyzed Wheat Protein, Tocopheryl Acetate, Melia Azadirachta Leaf Extract, Chamomilla Recutita Flower Exact, Xanthan Gum, Ethylhexyl glycerin, Sulfur, Disodium EDTA, Magnesium Aluminum Silicate, Hexylene Glycol.
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a46239a7-5963-4008-8cbb-6b9000f497eb | Product name | 1 | 20250721 |
| b382b4e1-6b48-45f6-bffc-e61b00b0ce19 | Product name | 3 | 20250317 |
| d9d61457-6a5a-41fc-b418-e5479a2904b7 | Product name | 2 | 20230303 |
| 32012d5c-25ac-49c7-9d4c-1313177fff7c | Product name | 1 | 20230112 |
| 13e7e7e3-e885-4c79-af6d-dad1aedbb06e | Product name | 1 | 20220128 |
| 4a7d44fe-774d-404b-aad0-8a90fe78375a | Product name | 4 | 20211025 |
| 3f45980c-c196-47e5-0e5e-48b7c57327c5 | Product name | 5 | 20200428 |
| d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b | Product name | 3 | 20200203 |
| ee5c6de5-d9cd-454f-b250-7b19e5cf2992 | Product name | 4 | 20190619 |
| ad75fcfd-a339-42a1-9c60-43ba2c654cfa | Product name | 1 | 20170810 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62742-4238-1 | CLEAROGEN 3 | 55 g in 1 TUBE | LOTION | 55 | 1 | |
| 62742-4238-2 | CLEAROGEN 3 | 30 g in 1 TUBE | LOTION | 30 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62742-4238 | CLEAROGEN 3 (BENZOYL PEROXIDE) LOTION [ALLURE LABS] | 1 | Current NDC, 2 package rows | 20231216_0bdf9f38-5763-a4d0-e063-6394a90a41dc.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62742-4238 | 62742-4238-1, 62742-4238-2 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CLEAROGEN 3 | BENZOYL PEROXIDE | Allure Labs | 0bdf9f38-5763-a4d0-e063-6394a90a41dc | 2023-12-06 | Warnings | 62742-4238-1 62742-4238-2 62742-4238 62742423802 62742423801 0bdf9f38-5764-a4d0-e063-6394a90a41dc 0bdf9f38-5763-a4d0-e063-6394a90a41dc |
Adverse event summaries are temporarily unavailable. Other product information remains available.